Tetrahydrozoline or tetryzoline
- Level
- Commodity
- Parent
- 51162700
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51162744This classification denotes an alpha-adrenergic agonist with the molecular formula C13H16N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S9U025Y077, chemically known as 4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-1h-imidazole but more generally known as tetrahydrozoline, which bears US NIH Compound Identifier 5419. European Medicines Agency schedules Tetryzoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10955MIG. The term TETRYZOLINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules tetrahydrozoline in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, TETRAHYDROZOLINE remains US FDA's Preferred Term for this commodity. Tetrahydrozoline bears US NLM identifiers UMLS ID C0076286 and NCI Concept Code C61967. SMILES: C1CC(C2=CC=CC=C2C1)C3=NCCN3.
Same parent
Under 51162700 · 48Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.